Xenon Pharmaceuticals (XENE) Tops Q2 EPS by $2.06

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of $1.07, $2.06 better than the analyst estimate of ($0.99).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Qualcomm (QCOM) Is Said To Near Deal For Ai Chip Startup Modular - Bloomberg
• Apollo Private Credit Fund caps redemptions at 5% - Bloomberg